| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/27/2023 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 40k | $6.50 | $260k | | 06/27/2023 |
| 05/25/2023 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.00 | $24k | | 05/25/2023 |
| 01/07/2023 | SpringWorks Therapeutics, Inc. | SWTX | Payment of Exercise | Common Stock | 4.1k | $26.41 | $108.2k | | 01/07/2023 |
| 01/06/2023 | SpringWorks Therapeutics, Inc. | SWTX | Payment of Exercise | Common Stock | 8.4k | $27.52 | $231.2k | | 01/05/2023 |
| 01/05/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | | 84.2k | $0.00 | $0 | | 01/05/2023 |
| 01/05/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 260k | $27.64 | $7.2M | | 01/05/2023 |
| 06/10/2022 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 18k | $4.18 | $75.2k | | 06/10/2022 |
| 05/26/2022 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.76 | $42.2k | | 05/26/2022 |
| 01/07/2022 | SpringWorks Therapeutics, Inc. | SWTX | Payment of Exercise | Common Stock | 4k | $56.06 | $224k | | 01/07/2022 |
| 01/07/2022 | SpringWorks Therapeutics, Inc. | SWTX | Payment of Exercise | Common Stock | 5.9k | $56.06 | $330.4k | | 01/07/2022 |
| 01/06/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | | 78.4k | $0.00 | $0 | | 01/06/2022 |
| 01/06/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 244.3k | $59.46 | $14.5M | | 01/06/2022 |
| 10/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 10.1k | $58.67 | $591.5k | | 10/20/2021 |
| 10/19/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 14.1k | $58.81 | $827.9k | | 10/18/2021 |
| 10/18/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 38.3k | $58.59 | $2.2M | | 10/18/2021 |
| 07/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 18.6k | $77.68 | $1.4M | | 07/19/2021 |
| 07/19/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 43.9k | $76.09 | $3.3M | | 07/19/2021 |
| 06/04/2021 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 15k | $28.83 | $432.4k | | 06/04/2021 |
| 05/27/2021 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 16.9k | $13.83 | $234k | | 05/27/2021 |
| 04/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 24.1k | $66.39 | $1.6M | | 04/19/2021 |
| 04/19/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 38.4k | $69.04 | $2.7M | | 04/19/2021 |
| 01/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 2.2k | $78.75 | $173.2k | | 01/19/2021 |
| 01/19/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 60.3k | $78.54 | $4.7M | | 01/19/2021 |
| 01/07/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 300k | $70.68 | $21.2M | | 01/07/2021 |
| 01/07/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 37.5k | $0.00 | $0 | | 01/07/2021 |
| 12/03/2020 | ARS Pharmaceuticals, Inc. | SBTX | Grant | Stock Option (right to buy) | 69.8k | $21.00 | $1.5M | | 12/03/2020 |
| 03/03/2020 | Passage BIO, Inc. | PASG | Purchase | Common Stock | 5k | $18.00 | $90k | | 03/03/2020 |
| 03/02/2020 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 325k | $33.66 | $10.9M | | 03/02/2020 |
| 02/27/2020 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 16.9k | $18.00 | $304.5k | | 02/27/2020 |
| 04/24/2013 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 75k | $89.23 | $6.7M | | 04/24/2013 |
| 04/24/2013 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 25k | $0.00 | $0 | | 04/24/2013 |